{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:09:29Z","timestamp":1791461369777,"version":"4.3.4"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2314-B-182A-050 -MY1-3"],"award-info":[{"award-number":["MOST 108-2314-B-182A-050 -MY1-3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3F, CFRPG3L0011, and BMRPF99"],"award-info":[{"award-number":["CMRPG3F, CFRPG3L0011, and BMRPF99"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CLRPG2C0021, CLRPG2C0022, CLRPG2C0023, CLRPG2C0024, and CLRPG2G0081"],"award-info":[{"award-number":["CLRPG2C0021, CLRPG2C0022, CLRPG2C0023, CLRPG2C0024, and CLRPG2G0081"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Angiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN). However, whether telmisartan, an ARB with peroxisome proliferator-activated receptor \u03b3 (PPAR-\u03b3)\u2013modulating effects, has additional benefits compared to other ARBs remains unclear.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods and findings<\/jats:title><jats:p>Between 1997 and 2013, 2,166,944 type 2 diabetes mellitus (T2DM) patients were identified from the National Health Insurance Research Database of Taiwan. Patients with HTN using ARBs were included in the study. Patients with a history of stroke, traumatic brain injury, or dementia were excluded. Finally, 65,511 eligible patients were divided into 2 groups: the telmisartan group and the non-telmisartan ARB group. Propensity score matching (1:4) was used to balance the distribution of baseline characteristics and medications. The primary outcome was the diagnosis of dementia. The secondary outcomes included the diagnosis of Alzheimer disease and occurrence of symptomatic ischemic stroke (IS), any IS, and all-cause mortality. The risks between groups were compared using a Cox proportional hazard model. Statistical significance was set at<jats:italic>p<\/jats:italic>&lt; 0.05. There were 2,280 and 9,120 patients in the telmisartan and non-telmisartan ARB groups, respectively. Patients in the telmisartan group had a lower risk of dementia diagnosis (telmisartan versus non-telmisartan ARBs: 2.19% versus 3.20%; HR, 0.72; 95% CI, 0.53 to 0.97;<jats:italic>p<\/jats:italic>= 0.030). They also had lower risk of dementia diagnosis with IS as a competing risk (subdistribution HR, 0.70; 95% CI, 0.51 to 0.95;<jats:italic>p<\/jats:italic>= 0.022) and with all-cause mortality as a competing risk (subdistribution HR, 0.71; 95% CI, 0.53 to 0.97;<jats:italic>p<\/jats:italic>= 0.029). In addition, the telmisartan users had a lower risk of any IS (6.84% versus 8.57%; HR, 0.79; 95% CI, 0.67 to 0.94;<jats:italic>p<\/jats:italic>= 0.008) during long-term follow-up. Study limitations included potential residual confounding by indication, interpretation of causal effects in an observational study, and bias caused by using diagnostic and medication codes to represent real clinical data.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Conclusions<\/jats:title><jats:p>The current study suggests that telmisartan use in hypertensive T2DM patients may be associated with a lower risk of dementia and any IS events in an East-Asian population.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pmed.1003707","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T17:22:10Z","timestamp":1626715330000},"page":"e1003707","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study"],"prefix":"10.1371","volume":"18","author":[{"given":"Chi-Hung","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-7583","authenticated-orcid":true,"given":"Pi-Shan","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-3473","authenticated-orcid":true,"given":"Yan-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7789-8347","authenticated-orcid":true,"given":"Wen-Kuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tay-Wey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3935-5963","authenticated-orcid":true,"given":"Tsong-Hai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-9765","authenticated-orcid":true,"given":"Tien-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-3134","authenticated-orcid":true,"given":"Yi-Chia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"issue":"19","key":"pmed.1003707.ref001","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"PK Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"pmed.1003707.ref002","doi-asserted-by":"crossref","first-page":"e0175475","DOI":"10.1371\/journal.pone.0175475","article-title":"Comorbidity and dementia: a nationwide survey in Taiwan","volume":"12","author":"TB Chen","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"pmed.1003707.ref003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.HYP.0000132374.90924.2a","article-title":"Preventing dementia by treating hypertension and preventing stroke","volume":"44","author":"JD Spence","year":"2004","journal-title":"Hypertension"},{"issue":"6","key":"pmed.1003707.ref004","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","article-title":"Impact of hypertension on cognitive function: a scientific statement from the American Heart Association","volume":"68","author":"C Iadecola","year":"2016","journal-title":"Hypertension"},{"issue":"2","key":"pmed.1003707.ref005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-161194","article-title":"Epidemiological approaches to understanding the link between type 2 diabetes and dementia","volume":"59","author":"GT Sutherland","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"pmed.1003707.ref006","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"JR Petrie","year":"2018","journal-title":"Can J Cardiol"},{"issue":"9841","key":"pmed.1003707.ref007","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: the bad companions","volume":"380","author":"E Ferrannini","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"pmed.1003707.ref008","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"GJ Biessels","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"pmed.1003707.ref009","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jalz.2019.06.001","article-title":"Preventing dementia by preventing stroke: the Berlin Manifesto","volume":"15","author":"V Hachinski","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"1","key":"pmed.1003707.ref010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"J Ding","year":"2020","journal-title":"Lancet Neurol"},{"issue":"3","key":"pmed.1003707.ref011","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis","volume":"94","author":"R Peters","year":"2020","journal-title":"Neurology"},{"issue":"Suppl 1","key":"pmed.1003707.ref012","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.2337\/dc21-S010","article-title":"Cardiovascular disease and risk management: Standards of Medical Care in Diabetes\u20132021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"issue":"6","key":"pmed.1003707.ref013","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41440-018-0034-4","article-title":"Hypertension with diabetes mellitus: physiology and pathology","volume":"41","author":"M Ohishi","year":"2018","journal-title":"Hypertens Res"},{"issue":"3","key":"pmed.1003707.ref014","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","article-title":"ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"139","author":"CE Evans","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"2","key":"pmed.1003707.ref015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000139656","article-title":"Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention","volume":"26","author":"A Towfighi","year":"2008","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"pmed.1003707.ref016","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11011-017-0050-0","article-title":"Insulin resistance in ischemic stroke","volume":"32","author":"XL Deng","year":"2017","journal-title":"Metab Brain Dis"},{"issue":"3","key":"pmed.1003707.ref017","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1212\/WNL.0000000000004110","article-title":"Insulin resistance among obese middle-aged is associated with decreased cerebrovascular reactivity","volume":"89","author":"OH Frosch","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"pmed.1003707.ref018","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1358\/dnp.2010.23.4.1437710","article-title":"Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents","volume":"23","author":"RK Kaundal","year":"2010","journal-title":"Drug News Perspect"},{"key":"pmed.1003707.ref019","first-page":"CD010693","article-title":"Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack","volume":"12","author":"J Liu","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"pmed.1003707.ref020","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jdiacomp.2017.01.006","article-title":"Effects of pioglitazone on the incidence of dementia in patients with diabetes","volume":"31","author":"PS Chou","year":"2017","journal-title":"J Diabetes Complications"},{"issue":"1","key":"pmed.1003707.ref021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13543784.2017.1265504","article-title":"Pioglitazone for the treatment of Alzheimer\u2019s disease","volume":"26","author":"D Galimberti","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"pmed.1003707.ref022","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamaneurol.2018.4406","article-title":"Potential new horizons for the prevention of cerebrovascular diseases and dementia","volume":"76","author":"L Pantoni","year":"2019","journal-title":"JAMA Neurol"},{"issue":"17","key":"pmed.1003707.ref023","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity","volume":"109","author":"M Schupp","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"pmed.1003707.ref024","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jash.2014.05.006","article-title":"A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients","volume":"8","author":"All-Literature Investigation of Cardiovascular Evidence Group","year":"2014","journal-title":"J Am Soc Hypertens"},{"issue":"6","key":"pmed.1003707.ref025","doi-asserted-by":"crossref","first-page":"e642","DOI":"10.1097\/MJT.0000000000000733","article-title":"Telmisartan improves insulin resistance: a meta-analysis","volume":"25","author":"Y Wang","year":"2018","journal-title":"Am J Ther"},{"issue":"2","key":"pmed.1003707.ref026","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.coph.2006.11.008","article-title":"Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect","volume":"7","author":"P Ernsberger","year":"2007","journal-title":"Curr Opin Pharmacol"},{"issue":"24","key":"pmed.1003707.ref027","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1212\/WNL.0000000000004741","article-title":"Blood pressure from mid- to late life and risk of incident dementia","volume":"89","author":"ER McGrath","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"pmed.1003707.ref028","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1212\/01.WNL.0000144278.79488.DD","article-title":"Diabetes mellitus in midlife and the risk of dementia three decades later","volume":"63","author":"M Schnaider Beeri","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"pmed.1003707.ref029","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/STROKEAHA.119.024156","article-title":"Risk factors for ischemic stroke in younger adults: a focused update","volume":"51","author":"MG George","year":"2020","journal-title":"Stroke"},{"key":"pmed.1003707.ref030","doi-asserted-by":"crossref","first-page":"j2856","DOI":"10.1136\/bmj.j2856","article-title":"Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study","volume":"358","author":"S Ahmadi-Abhari","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"pmed.1003707.ref031","doi-asserted-by":"crossref","first-page":"e112257","DOI":"10.1371\/journal.pone.0112257","article-title":"Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan","volume":"9","author":"CS Wu","year":"2014","journal-title":"PLoS ONE"},{"key":"pmed.1003707.ref032","first-page":"1756286418802688","article-title":"Choices for long-term hypertensive control in patients after first-ever hemorrhagic stroke: a nationwide cohort study","volume":"11","author":"CH Liu","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"pmed.1003707.ref033","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12933-019-0979-x","article-title":"Pioglitazone and PPAR-gamma modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study","volume":"19","author":"CH Liu","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"pmed.1003707.ref034","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"RA Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"pmed.1003707.ref035","doi-asserted-by":"crossref","first-page":"e2015189","DOI":"10.1001\/jamanetworkopen.2020.15189","article-title":"Type of androgen deprivation therapy and risk of dementia among patients with prostate cancer in Taiwan","volume":"3","author":"WK Huang","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"pmed.1003707.ref036","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-190762","article-title":"the impact of antiplatelet use on the risk of intracerebral hemorrhage in patients with Alzheimer\u2019s disease: a nationwide cohort study","volume":"73","author":"TL Lee","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"pmed.1003707.ref037","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jfma.2013.09.009","article-title":"Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database","volume":"114","author":"CY Hsieh","year":"2015","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"pmed.1003707.ref038","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/HYPERTENSIONAHA.120.16080","article-title":"Hypertension, prehypertension, and hypertension control: association with decline in cognitive performance in the ELSA-Brasil cohort","volume":"77","author":"ST de Menezes","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"pmed.1003707.ref039","first-page":"291","article-title":"The relationship between blood pressure and cognitive performance in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"66","author":"JA Suhr","year":"2004","journal-title":"Psychosom Med"},{"issue":"10","key":"pmed.1003707.ref040","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1474-4422(19)30228-5","article-title":"Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study","volume":"18","author":"CA Lane","year":"2019","journal-title":"Lancet Neurol"},{"issue":"15","key":"pmed.1003707.ref041","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/CIRCULATIONAHA.113.004798","article-title":"Early adult to midlife cardiovascular risk factors and cognitive function","volume":"129","author":"K Yaffe","year":"2014","journal-title":"Circulation"},{"issue":"19","key":"pmed.1003707.ref042","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis","volume":"323","author":"D Hughes","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"pmed.1003707.ref043","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/HJH.0000000000001829","article-title":"Blood pressure-lowering interventions to prevent dementia: a systematic review and meta-analysis","volume":"36","author":"T van Middelaar","year":"2018","journal-title":"J Hypertens"},{"issue":"5","key":"pmed.1003707.ref044","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"SC Benson","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"pmed.1003707.ref045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fca-2017-0019","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-beta\/delta and PPAR-gamma","volume":"13","author":"L Han","year":"2017","journal-title":"Future Cardiol"},{"issue":"1","key":"pmed.1003707.ref046","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"V Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"pmed.1003707.ref047","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"GJ Biessels","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"pmed.1003707.ref048","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1570159X16666180828100002","article-title":"Current progress on peroxisome proliferator-activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer\u2019s disease: an update","volume":"17","author":"MA Khan","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"14","key":"pmed.1003707.ref049","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"WN Kernan","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"pmed.1003707.ref050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/STROKEAHA.116.013977","article-title":"Pioglitazone for secondary stroke prevention: a systematic review and meta-analysis","volume":"48","author":"M Lee","year":"2017","journal-title":"Stroke"},{"issue":"2","key":"pmed.1003707.ref051","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.24439","article-title":"Effect of pioglitazone medication on the incidence of dementia","volume":"78","author":"MT Heneka","year":"2015","journal-title":"Ann Neurol"},{"issue":"4","key":"pmed.1003707.ref052","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1016\/j.bbrc.2018.08.091","article-title":"Effects of telmisartan on TNFalpha induced PPARgamma phosphorylation and insulin resistance in adipocytes","volume":"503","author":"T Fang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"pmed.1003707.ref053","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12933-019-0829-x","article-title":"Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype","volume":"18","author":"D Mori","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"pmed.1003707.ref054","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1515\/revneuro-2016-0055","article-title":"Leptin and adiponectin: pathophysiological role and possible therapeutic target of inflammation in ischemic stroke","volume":"28","author":"J Gairolla","year":"2017","journal-title":"Rev Neurosci"},{"issue":"8","key":"pmed.1003707.ref055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/hr.2010.107","article-title":"Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan","volume":"33","author":"T Wago","year":"2010","journal-title":"Hypertens Res"},{"issue":"12","key":"pmed.1003707.ref056","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"S Yusuf","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"pmed.1003707.ref057","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/01.hjh.0000357906.60778.7f","article-title":"Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs","volume":"27","author":"HC Diener","year":"2009","journal-title":"J Hypertens Suppl"},{"issue":"6","key":"pmed.1003707.ref058","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jjcc.2012.08.004","article-title":"Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor\/tropomyosin-related kinase B in hippocampus of hypertensive rats","volume":"60","author":"T Kishi","year":"2012","journal-title":"J Cardiol"},{"issue":"4","key":"pmed.1003707.ref059","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/HYPERTENSIONAHA.109.136879","article-title":"Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation","volume":"54","author":"K Tsukuda","year":"2009","journal-title":"Hypertension"},{"issue":"2","key":"pmed.1003707.ref060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.01.025","article-title":"Effect of telmisartan on preventing learning and memory deficits via peroxisome proliferator-activated receptor-gamma in vascular dementia spontaneously hypertensive rats","volume":"27","author":"Y Gao","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"Suppl 4","key":"pmed.1003707.ref061","doi-asserted-by":"crossref","first-page":"S575","DOI":"10.3233\/JAD-141284","article-title":"Renin angiotensin aldosterone system inhibition in controlling dementia-related cognitive decline","volume":"42","author":"R O\u2019Caoimh","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"pmed.1003707.ref062","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in Alzheimer\u2019s disease: progress toward disease prevention and treatment?","volume":"62","author":"PG Kehoe","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"pmed.1003707.ref063","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/joim.12838","article-title":"Connecting the brain cholesterol and renin-angiotensin systems: potential role of statins and RAS-modifying medications in dementia","volume":"284","author":"B Petek","year":"2018","journal-title":"J Intern Med"},{"issue":"1","key":"pmed.1003707.ref064","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","article-title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies","volume":"10","author":"C Anderson","year":"2011","journal-title":"Lancet Neurol"},{"issue":"7","key":"pmed.1003707.ref065","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/HJH.0b013e3280825625","article-title":"Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring","volume":"25","author":"MJ Fabia","year":"2007","journal-title":"J Hypertens"},{"issue":"12","key":"pmed.1003707.ref066","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ajh\/hpu076","article-title":"Telmisartan exerts sustained blood pressure control and reduces blood pressure variability in metabolic syndrome by inhibiting sympathetic activity","volume":"27","author":"D Sueta","year":"2014","journal-title":"Am J Hypertens"},{"issue":"2","key":"pmed.1003707.ref067","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jch.13451","article-title":"Morning surge in blood pressure and blood pressure variability in Asia: evidence and statement from the HOPE Asia Network","volume":"21","author":"GP Sogunuru","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"19","key":"pmed.1003707.ref068","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jacc.2020.03.043","article-title":"blood pressure variation and subclinical brain disease","volume":"75","author":"Y Ma","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"pmed.1003707.ref069","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.116.025667","article-title":"Day-to-day blood pressure variability and risk of dementia in a general Japanese elderly population: the Hisayama Study","volume":"136","author":"E Oishi","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"pmed.1003707.ref070","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/ATVBAHA.117.309298","article-title":"Blood pressure and heart rate measures associated with increased risk of covert brain infarction and worsening leukoaraiosis in older adults","volume":"37","author":"LY Leung","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"pmed.1003707.ref071","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline","volume":"348","author":"SE Vermeer","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"pmed.1003707.ref072","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ana.25228","article-title":"Blood pressure and risk of incident Alzheimer\u2019s disease dementia by antihypertensive medications and APOE epsilon4 allele","volume":"83","author":"KB Rajan","year":"2018","journal-title":"Ann Neurol"},{"issue":"6","key":"pmed.1003707.ref073","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Sprint Mind Investigators for the SPRINT Research Group","year":"2019","journal-title":"JAMA"},{"key":"pmed.1003707.ref074","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/VHRM.S7857","article-title":"New standards in hypertension and cardiovascular risk management: focus on telmisartan","volume":"6","author":"D Galzerano","year":"2010","journal-title":"Vasc Health Risk Manag"},{"issue":"6","key":"pmed.1003707.ref075","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.ajkd.2019.05.017","article-title":"Cognitive impairment in CKD: pathophysiology, management, and prevention","volume":"74","author":"DA Drew","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"pmed.1003707.ref076","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3233\/JAD-180141","article-title":"differences between women and men in incidence rates of dementia and Alzheimer\u2019s disease","volume":"64","author":"CR Beam","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"pmed.1003707.ref077","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1161\/STROKEAHA.120.031707","article-title":"Stroke prevention in older adults: recent advances","volume":"51","author":"JD Spence","year":"2020","journal-title":"Stroke"},{"issue":"5","key":"pmed.1003707.ref078","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc15-2283","article-title":"Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes","volume":"39","author":"Accord Study Group","year":"2016","journal-title":"Diabetes Care"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T06:49:12Z","timestamp":1699253352000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003707"}},"subtitle":[],"editor":[{"given":"Carol","family":"Brayne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":78,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003707","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]}}}